Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, inc...
Q1 2026
May 6, 2026
FY 2025
Mar 23, 2026
Q4 2025
Q3 2025
Nov 7, 2025
Q2 2025
Aug 8, 2025